Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI AgentsNews DeskAugust 4, 20260 Pathos AI, a startup that developed artificial intelligence-enabled technologies for cancer drug research, has secured rights to two molecules whose…